Unmodificated stepless regulation of CRISPR/Cas12a multi-performance
Rong Zhao,Wang Luo,You Wu,Li Zhang,Xin Liu,Junjie Li,Yujun Yang,Li Wang,Luojia Wang,Xiaole Han,Zhongzhong Wang,Jianhong Zhang,Ke Lv,Tingmei Chen,Guoming Xie
DOI: https://doi.org/10.1093/nar/gkad748
IF: 14.9
2023-09-28
Nucleic Acids Research
Abstract:As CRISPR technology is promoted to more fine-divided molecular biology applications, its inherent performance finds it increasingly difficult to cope with diverse needs in these different fields, and how to more accurately control the performance has become a key issue to develop CRISPR technology to a new stage. Herein, we propose a CRISPR/Cas12a regulation strategy based on the powerful programmability of nucleic acid nanotechnology. Unlike previous difficult and rigid regulation of core components Cas nuclease and crRNA, only a simple switch of different external RNA accessories is required to change the reaction kinetics or thermodynamics, thereby finely and almost steplessly regulating multi-performance of CRISPR/Cas12a including activity, speed, specificity, compatibility, programmability and sensitivity. In particular, the significantly improved specificity is expected to mark advance the accuracy of molecular detection and the safety of gene editing. In addition, this strategy was applied to regulate the delayed activation of Cas12a, overcoming the compatibility problem of the one-pot assay without any physical separation or external stimulation, and demonstrating great potential for fine-grained control of CRISPR. This simple but powerful CRISPR regulation strategy without any component modification has pioneering flexibility and versatility, and will unlock the potential for deeper applications of CRISPR technology in many finely divided fields.
biochemistry & molecular biology